Pfizer's Lipitor Approved to Prevent Heart Attack, Stroke in Type 2 Diabetics

Drug Industry Daily
KEYWORDS Drug Approvals / NDA

The FDA has approved Pfizer’s cholesterol-lowering drug Lipitor as a treatment to reduce the risk of stroke and heart attack in diabetic patients, expanding the potential patient population for what is already the world’s top-selling pharmaceutical product.

To View This Article:


Subscribe To Drug Industry Daily